Home › Trial NCT02148562
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
- Trial IDNCT02148562
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorUniversitaire Ziekenhuizen KU Leuven
- Enrollment274
- Start date2014-04
- ConditionsHepatitis B · Hepatitis B, Chronic · End Stage Liver Disease · Carcinoma, Hepatocellular
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.